China SXT Pharmaceuticals Inc Capital Reinvestment Ratio
China SXT Pharmaceuticals Inc capital reinvestment ratio. China SXT Pharmaceuticals Inc (SXTC) has a Capital Reinvestment Ratio of 0.11x as of December 2022, meaning it reinvests 0% of its operating cash flow ($234.18K) in capital expenditures ($25.28K). Check SXTC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of China SXT Pharmaceuticals Inc (2016–2020)
Capital reinvestment ratio of China SXT Pharmaceuticals Inc from 2016 to 2020. This chart tracks China SXT Pharmaceuticals Inc's Capital Reinvestment Ratio across 5 annual periods. Also explore how fast is China SXT Pharmaceuticals Inc growing its equity to track the company's year-over-year net asset growth rate.
China SXT Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2016–2020)
China SXT Pharmaceuticals Inc capital reinvestment ratio by year from 2016 to 2020. For the full cash flow conversion analysis, see how efficiently does China SXT Pharmaceuticals Inc generate cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.44x | $934.25K | $406.66K | ▼ -82.9% |
| 2019 | 2.55x | $239.19K | $610.09K | ▲ +366.1% |
| 2018 | 0.55x | $1.92 Million | $1.05 Million | ▼ -13.9% |
| 2017 | 0.64x | $293.04K | $186.31K | ▲ +19.6% |
| 2016 | 0.53x | $182.47K | $96.99K | — |